J&J Has Kenvue IPO Roadshow In One Lane, Potentially Long Road For Talc Litigation In Other
Executive Summary
Roadshow stated for IPO planned for before end of 2023 of 151.2m shares of Kenvue common stock currently expected at between $20 and $23 per share. Analysts positive on IPO but caution launch wouldn’t come problem-free.
You may also be interested in...
In Vivo’s Deals Of The Year: Cast Your Vote!
It is time for In Vivo's 16th annual Deals of the Year contest. We've selected 12 nominees across three categories – Top M&A, Top Alliance and Top Financing – and you get to pick the winners.
Kenvue Reaches Canada With Zarbees Line As J&J Reaches Final Step Of Spinoff Share Exchange
Kenvue gets Canada as a market for Zarbees honey-based children’s products while J&J expects nearly 200m of its shares to be exchanged for Kenvue shares.
Kenvue's Debut Shares Spotlight With J&J's Plan
Announced first results as standalone firm, Kenveu doesn’t downplay significance of J&J announcing its plan for selling shares from nearly 90% ownership it retained after spinning off Kenvue out in May.